Alarming heart disease trend found in transgender hormone users.
A New Danish Study Reveals Alarming Heart Disease Risks for Transgender Individuals
A groundbreaking Danish study published in the European Journal of Endocrinology has shed light on the significant cardiovascular risks faced by transgender individuals undergoing cross-sex hormone therapy.
The study, which included 2,671 transgender individuals in their early to mid-20s from Denmark, found that those taking cross-sex hormones had a significantly higher risk of developing heart disease compared to the control group.
Related Stories
The study revealed that transgender individuals on cross-sex hormones were more likely to develop high blood pressure, elevated cholesterol levels, and experience life-threatening heart attacks and strokes.
Of particular concern were biological men taking feminizing hormones, who faced a staggering 93% increased risk of heart ailments compared to men not receiving hormone therapy. They also had a 73% greater risk than biological women in the control group.
Similarly, biological women taking testosterone had a 63% higher risk of heart disease compared to women not undergoing hormone therapy. They were also twice as likely to develop cardiovascular issues compared to biological men in the control group.
This study aligns with previous research conducted at Mercy Catholic Medical Center, which also highlighted the potential dangers of hormone treatments for individuals with gender dysphoria.
These findings contribute to the growing body of evidence suggesting that hormone treatments for gender dysphoria may pose life-threatening risks. As a result, there is a movement in Republican-led states to ban such treatments for minors.
Dr. Eduardo Balbona, an internal medicine specialist in Jacksonville, Florida, expressed his lack of surprise at the study’s results. He has encountered transgender patients taking dangerously high hormone doses and believes it is crucial to draw the line at providing care that could be lethal.
“You shouldn’t be doing things that are going to kill you,” Dr. Balbona emphasized, recounting a conversation with a male patient transitioning to a female identity.
Dr. Balbona has witnessed patients taking over five times the typical dose of estrogen, which can significantly increase the risk of fatal blood clots. He also noted a male patient taking excessively high doses of Spironolactone, a testosterone blocker that can raise potassium levels and potentially stop the heart from beating.
While proponents argue that hormone therapy saves lives by reducing suicidal tendencies in gender dysphoric individuals, critics question the health risks and the ultimate satisfaction achieved through transitioning procedures.
As the evidence continues to mount, it becomes increasingly clear that hormone ”therapy” may be a fatal attraction for those grappling with their gender identity.
The Danish study identified elevated cholesterol and high blood pressure as the most common cardiovascular issues among transgender individuals on hormone therapy. However, further research is needed to explore additional factors that may contribute to increased cardiovascular risk.
Dr. Dorte Glintborg, from the Department of Endocrinology at Odense University Hospital in Denmark, emphasized the importance of long-term data to better understand the impact of hormone therapy on cardiovascular health. She also suggested that mental support as part of transgender care could potentially mitigate minority stress and protect against the development of cardiovascular disease.
Another study conducted at Mercy Catholic Medical Center found that gender dysphoric patients on hormones were significantly more likely to experience ischemic strokes, heart attacks, and pulmonary embolisms compared to those not undergoing hormone therapy.
Dr. Ibrahim Ahmed, the lead author of the Mercy study, emphasized that transgender patients must be aware that hormone therapy carries inherent risks and is not a risk-free endeavor.
As the debate surrounding transgender healthcare continues, it is crucial to consider the potential dangers and long-term consequences of hormone treatments. Balancing the desire for gender affirmation with the preservation of overall health remains a complex challenge.
Bill Pan contributed to this report.
What are the potential long-term effects of hormone treatments on cardiovascular health?
Cardiovascular risks and potential long-term effects of hormone treatments.
In conclusion, this groundbreaking Danish study has shed light on the alarming heart disease risks faced by transgender individuals undergoing cross-sex hormone therapy. The findings indicate a significantly higher risk of developing heart disease among those taking cross-sex hormones compared to the control group. This risk is particularly pronounced in biological men taking feminizing hormones, who face a staggering 93% increased risk compared to men not receiving hormone therapy. Similarly, biological women taking testosterone have a 63% higher risk of heart disease compared to women not undergoing hormone therapy. These findings align with previous research and highlight the potential dangers of hormone treatments for individuals with gender dysphoria.
The study’s results have sparked a movement in Republican-led states to ban hormone treatments for minors, as evidence suggests that these treatments may pose life-threatening risks. Medical professionals also emphasize the importance of providing care that does not put patients at risk of harm. Critics question the health risks and long-term satisfaction achieved through transitioning procedures, while proponents argue that hormone therapy saves lives by reducing suicidal tendencies in gender dysphoric individuals.
While elevated cholesterol and high blood pressure were identified as the most common cardiovascular issues among transgender individuals on hormone therapy, further research is needed to explore additional risks and potential long-term effects. As the evidence continues to mount, it becomes increasingly clear that hormone “therapy” may be a fatal attraction for those grappling with their gender identity
" Conservative News Daily does not always share or support the views and opinions expressed here; they are just those of the writer."
*As an Amazon Associate I earn from qualifying purchases
Now loading...